Hinge Health (NYSE:HNGE) Research Coverage Started at Bank of America

Bank of America started coverage on shares of Hinge Health (NYSE:HNGE) in a research note published on Monday, MarketBeat Ratings reports. The firm issued a buy rating and a $42.00 target price on the stock.

Other research analysts have also issued research reports about the company. Barclays began coverage on Hinge Health in a report on Monday. They set an “overweight” rating and a $43.00 price objective on the stock. Needham & Company LLC began coverage on shares of Hinge Health in a research report on Monday. They set a “buy” rating and a $47.00 target price on the stock. Canaccord Genuity Group assumed coverage on shares of Hinge Health in a report on Monday. They issued a “buy” rating and a $52.00 price target for the company. Wall Street Zen upgraded shares of Hinge Health to a “hold” rating in a research note on Monday, June 2nd. Finally, KeyCorp initiated coverage on shares of Hinge Health in a report on Monday. They set an “overweight” rating and a $45.00 price objective on the stock. One investment analyst has rated the stock with a hold rating and thirteen have issued a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $46.00.

Hinge Health Trading Up 4.7%

NYSE HNGE opened at $39.79 on Monday. Hinge Health has a 12-month low of $33.42 and a 12-month high of $43.80.

Hinge Health Company Profile

Our vision is to build a new health system that transforms outcomes, experience and costs by using technology to scale and automate the delivery of care. Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients.